Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1038 of 5804
-
Glow-in-the-dark dye could help surgeons spot hidden cancer during head and neck surgery
Diagnosis Recruiting nowThis study is for adult patients with head and neck cancer who are at risk of recurrence. The purpose of this study is to evaluate whether the use of Indocyanine Green (ICG) dye allows for better identification of tumor tissue during surgical procedures. Participation will includ…
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New drug combo aims to tame Crohn's Flare-Ups
Disease control Recruiting nowThe main purpose of this study is to see how the safety and efficacy of a farnesoid X receptor (FXR) agonist (LY4395089), given together with mirikizumab compares with mirikizumab (alone) in adults with moderately to severely active Crohn's disease (CD). This study is part of the…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New app could help kids with diabetes dose insulin safely
Disease control Recruiting nowThis is a multi-centre, prospective, randomized, open-label controlled trial designed to evaluate the effectiveness of a flexible digital insulin dose calculator in children under 12 years of age with Type 1 Diabetes Mellitus (T1DM) managed with multiple daily injections (MDI). P…
Phase: NA • Sponsor: Sultan Qaboos University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could an old drug save your sight? disulfiram trial targets vision loss
Disease control Recruiting nowAberrant retinoic acid signaling driven by the degenerating outer retina leads to pathological changes to the inner retina. The resulting hyperactivity of retinal ganglion cells leads to further diminution of the remaining vision in those afflicted with inherited retinal diseases…
Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Integrated therapy module aims to tackle dual burden of depression and addiction in pakistani men
Disease control OngoingThe purpose of this study is to evaluate the adaptation and effectiveness of an integrated treatment module, the Depression and Substance Use Disorder Module (D-SUD-M), for male patients experiencing co-occurring depression and substance use disorders in Pakistan. Participants a…
Phase: NA • Sponsor: International Islamic University, Islamabad • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
One-Hour test could revolutionize pneumonia treatment in hospitals
Diagnosis Not yet recruitingMultidrug-resistant bacterial infections are a growing global health concern. Hospital-acquired pneumonia is one of the most common infections occurring during hospitalization and can be associated with high mortality, reaching up to 50% in severe cases. One of the main reasons f…
Phase: NA • Sponsor: Hospital de Clinicas de Porto Alegre • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
Two-Week summer program aims to ease OCD in teens
Symptom relief Not yet recruitingThe aim of the study is to examine the effectiveness of OCD treatment delivered in a group format for adolescents during a two week intensive summer treatment program.
Phase: NA • Sponsor: University of Iceland • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Family lifestyle program may delay early puberty in at-risk girls
Disease control Not yet recruitingThis study is testing whether improving health in girls during the prepubertal period may slow the onset of puberty. This study will focus on prepubertal girls who have a high weight status (at or above the 85th percentile for body mass index). Half of the girls who join the stud…
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Shock therapy without the shock? new brain zaps aim to lift mood and kill pain
Symptom relief Not yet recruitingThis clinical trial aims to investigate a novel non-pharmacological intervention, transcranial electrical stimulation (tES), for the treatment of comorbid depression and chronic pain. The primary objectives are to optimize neurostimulation parameters through a multicenter randomi…
Phase: NA • Sponsor: Shanghai Mental Health Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Experimental cell therapy takes aim at Hard-to-Treat kidney cancer
Disease control Not yet recruitingThis is a single-arm, open-label, exploratory clinical study to evaluate the safety and preliminary efficacy of UCL70805F in patients with CD70-positive advanced renal clear cell carcinoma.
Phase: PHASE1 • Sponsor: UTC Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New scan duo could spot stomach cancer more clearly
Diagnosis Not yet recruitingThe purpose of this study was to evaluate the diagnostic efficacy and prognostic value of 18F-FAPI PET/CT combined with multiparameter MRI in gastric cancer.
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
New study pits elagolix against birth control pills for endometriosis pain relief
Symptom relief ENROLLING_BY_INVITATIONThis study is designed to provide direct evidence on the relative effectiveness and safety of Elagolix versus OCPs, helping physicians make more tailored treatment decisions.
Phase: PHASE4 • Sponsor: Pak Emirates Military Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New pill targets Hard-to-Treat cancers in early human trial
Disease control Not yet recruitingThe goal of this study is to learn if KQB368 works to treat advanced solid malignancies in adults. The study will also learn about the safety of KQB368. The main questions the study aims to answer are: * What is the safe dose of KQB368 as a monotherapy? * Does KQB368 decrease th…
Phase: PHASE1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New DA-001 hair loss treatment heads to Large-Scale trial
Disease control Not yet recruitingThe primary objective of the study is to assess the safety and efficacy of DA-001 as a treatment for Hair Shedding Reduction and Hair Re-Growth
Phase: PHASE2, PHASE3 • Sponsor: Applied Biology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New ultrasound could predict chemo success in weeks, not months
Diagnosis Not yet recruitingGastric cancer is a common type of cancer that often spreads to the liver. When cancer spreads to the liver, treatment becomes very difficult. Many patients will undergo chemotherapy to shrink the tumor. Currently, doctors use CT or MRI scans to assess the effect of chemotherapy,…
Sponsor: The First Hospital of Jilin University • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
New cell therapy aims to boost hearing restoration in cochlear implant patients
Disease control Not yet recruitingRinri Therapeutics is conducting a clinical trial of a new cell therapy called Rincell-1. Rincell-1 is being developed to treat adults with neural hearing loss, either age related hearing loss or auditory neuropathy, who also meet criteria for a cochlear implant. The goals of thi…
Phase: PHASE1, PHASE2 • Sponsor: Rinri Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
3D movies could be a fun new treatment for lazy eye in children
Symptom relief Not yet recruitingAmblyopia is a common childhood visual disorder that affects vision in one eye and can also impair depth perception (stereopsis). Standard treatment typically involves occlusion therapy (patching the stronger eye), which improves visual acuity but often does not fully restore bin…
Phase: NA • Sponsor: Universitat Politècnica de Catalunya • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New sensor could help doctors drain fluid from heart failure Patients' lungs
Disease control OngoingHeart failure (HF) is a leading cause of hospitalization, with high rates of early readmission largely driven by residual congestion at discharge. Conventional methods to assess congestion are often imprecise and may fail to guide optimal decongestive therapy. Remote Dielectric …
Phase: NA • Sponsor: Instituto Cardiovascular de Buenos Aires • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New study aims to help women bounce back after abuse
Symptom relief Not yet recruitingThe EMBER-protocol is an intervention used at the NCK clinic at Uppsala University Hospital with the purpose of helping women utilize their resilience and strengths in order to recover after intimate partner violence. This study is conducted in order to explore how health and res…
Sponsor: Uppsala University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New study offers lifesaving lifestyle coaching to childhood cancer survivors
Disease control Not yet recruitingSurvivors of childhood cancer have a substantially increased risk of long-term health problems in adulthood, including cardiovascular disease, metabolic disorders, psychological morbidity, and impaired health-related quality of life (HRQoL). These risks are partly related to canc…
Phase: NA • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC